Aethon
Aethon is the leading maker of practical, dependable courier robots for hospitals. Our team consists of hospital environment experts with over 100 years combined robotic experience in healthcare, so we understand the people and processes involved in running a hospital. We've used that knowledge to develop an automated technology platform that helps increase productivity and staff satisfaction, while saving hospitals time and money.
www.aethon.com
MAST Biosurgery AG
MAST Biosurgery is an innovative biomaterials company specializing on the develepment and distribution of products for post-surgical adhesion prevention. Key therapeutic areas are general surgery, obstetrics/gyneco-logy, open heart surgery and orthopedics. It is headquatered in Zürich, Switzerland, with a subsidiary in San Diego, USA. It has its proprietary distribution system in the USA and a global network of distributors.
www.mastbio.com
Mini-LAP
Mini-Lap Technologies has developed novel instrumentation for use in laparoscopic surgery. The aim of the technology is to increase surgical options by taking the cost and guesswork out of placing trocars used in the insertion of ancillary surgical instruments such as grabbers, tissue stabilizers and electro-cautery.
The instrumentation has been developed by a surgeon with the patient, clinician and administrator in mind. As the company is early in its life, the product line, which is based on a platform technology [patent pending] will continue to expand to enable the surgeon to address a broader range of clinical challenges.Mini-Lap instruments have been cleared by the FDA for general use in laparoscopic surgery procedures
By integrating the instrument and the delivery conduit in a disposable instrument, Mini-Lap helps the surgical administrator to control costs, minimize surgical scaring, improve patient comfort and increase the options available to the surgeon.
www.mini-lap.com
MYOSCIENCE
MyoScience Inc., founded in 2005 with headquarters in Redwood City, California, is a clinical development stage company dedicated to developing and commercializing innovative technology driven products for aesthetic medicine.
www.myoscience.com
Patholase Inc.
PathoLase, Inc. is a developing light-based disinfectant devices and procedures to treat diseases caused by viral, bacterial & fungal pathogens in human tissue.
We are currently developing and licensing proven procedures and associated devices for the eradication of the fungus (Trichophyton rubrum) which is the primary pathogen responsible for toe nail fungus (Onychomycosis), currently affecting 10 million individuals in the US.
We are also targeting the bacteria (Porphyromonas gingivalis) that has been linked to pancreatic cancer and heart disease as well as causing periodontal disease which is responsible for tooth loss in 50% of the US population.
www.patholase.com
SABAL MEDICAL Inc.
Leveraging years of experience in healthcare, automation, and information technology, the leadership at Sabal is driving patient safety to a whole new level. Sabal’s MedCenter™ helps nurses and pharmacists close the loop so they can provide the absolute best, safest care possible by accessing and administering meds at the bedside. What sets our system apart from all the rest is that our software controls access to medications, reducing “work arounds”, and potential for errors. It is very lightweight but has a high capacity to accommodate narcotics.
www.sabalmedical.com
Vital Sensors Inc.
Vital Sensors develops permanent intracardiac monitoring devices that aid in the management of patients with severe heart failure. The first product has successfully passed the first in human stage and controlled clinical trials will start soon. The technology is wireless and free of batteries and thus optimally suited for long term monitoring use.
www.vitalsensors.com
Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Its products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line is an endovascular system that enables a physician to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. The company believes its products provide a safe and reliable alternative to more invasive neurosurgical procedures for treating aneurysms. Their proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. They also sell accessory devices and products used in conjunction with our microcoils.
(divested 2002) |
